Canada markets closed

Bolt Biotherapeutics, Inc. (BOLT)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
1.1100-0.0400 (-3.48%)
At close: 04:00PM EDT
1.1100 0.00 (0.00%)
After hours: 07:22PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
7,876
7,876
5,729
1,260
231
Operating Expenses
Research Development
61,542
61,542
73,123
75,655
40,357
Selling General and Administrative
22,530
22,530
22,927
18,393
9,056
Total Operating Expenses
84,072
84,072
96,050
94,048
49,413
Operating Income or Loss
-76,196
-76,196
-90,321
-92,788
-49,182
Total Other Income/Expenses Net
-
-
-
-6,084
-11,745
Income Before Tax
-69,197
-69,197
-88,098
-98,591
-60,728
Income from Continuing Operations
-69,197
-69,197
-88,098
-98,591
-60,728
Net Income
-69,197
-69,197
-88,098
-98,591
-60,728
Net Income available to common shareholders
-69,197
-69,197
-88,098
-98,591
-60,728
Basic EPS
-1.89
-
-2.36
-2.97
-1.91
Diluted EPS
-1.89
-
-2.36
-2.97
-1.91
Basic Average Shares
37,715
-
37,358
33,197
31,847
Diluted Average Shares
37,715
-
37,358
33,197
31,847